Low High Density Lipoproteins in sepsis: an associated factor with worst prognosis

Authors

  • Carlos Tejeda-Jaraba Hospital General del Sur “Dr. Pedro Iturbe”. Universidad del Zulia. Maracaibo, Venezuela.
  • Akbal Echtay-Martínez Centro Médico de Cabimas. Cabimas, Venezuela
  • Cristobal Espinoza-Díaz Universidad Católica de Cuenca, Cuenca, Ecuador
  • Ana Herrera-Castillo Universidad Técnica de Machala, Machala, Ecuador
  • Roberto Añez Hospital General Universitario Gregorio Marañón, Madrid, España
  • Juan Salazar Centro de Investigaciones Endocrino Metabólicas Dr. Félix Gómez. Universidad del Zulia. Maracaibo, Venezuela

DOI:

https://doi.org/10.17081/innosa.92

Keywords:

Sepsis, Lipoproteins, HDL2, Shock Septic, Multiple Organ Failure

Abstract

Introduction: Sepsis is a frequent disease that cause a high morbidity and mortality in the adult population that consult to the emergency services, the dysregulated inflammatory response that characterizes it can be modulated by high density lipoprotein levels, thus the objective of this study was to determinate the association between high density lipoprotein levels and complications in patients with sepsis diagnosis. Materials and Methods: An observational, prospective study was carried out with a non-experimental design, whose population were 60 subjects of both genders with sepsis diagnosis. The data was collected using a form that included: identification data, clinical data such as: blood pressure, heart rate, respiratory rate, Glasgow coma scale and laboratory data: leukocytes, HDL-C level, creatinine, total bilirubin, platelets, diuresis, PaO2/FiO2, and coagulation profile. Results: Of the total sample, 58.3% (n=35) presented complications such as septic shock or multi-organ failure, with a higher percentage in those with lower HDL-C (HDL-C <30mg/dl: 82.8% vs HDL-C ≥30: 35.5% (χ2=13.78, p<0.01). Similarly, this group required greater use of vasoactive agents (χ2=36.47, p<0.01). While clinical parameters such as systolic blood pressure, Glasgow coma scale, platelets and PaO2 / FiO2 showed a lower average in patients with HDL-C <30 mg/dl Conclusion: Serum levels of HDL-C<30 mg/dl were associated with a higher percentage of patients that evolved to septic shock, requirement of vasoactive agents and multi-organ failure.

Downloads

Download data is not yet available.

References

Singer M, Deutschman C, Warren Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. The Third

International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.

DOI: 10.1001/jama.2016.0287

Kempker JA., Martin GS. The Changing Epidemiology and Definitions of Sepsis. Clin Chest Med.

;37(2):165-79. DOI: 10.1016/j.ccm.2016.01.002

Biron BM, Lomas-Neira JL. Biomarkers for Sepsis: What Is and What Might Be? Biomark Insights. 2015;

(Suppl 4): 7–17. DOI: 10.4137/BMI.S29519

Salazar J, Cabrera M, Ramos E, Olivar L, Aguirre M, Rojas J, et al. HDL-C y riesgo de aterosclerosis.

Diabetes Internacional. 2013;5(2):42-54.

Contreras S, Varas P, Awad F, Busso D, Rigotti A. Papel protector de las lipoproteínas de alta densidad en

sepsis: aspectos básicos e implicancias clínicas. Rev Chilena Infectol. 2004;31 (1): 34-43. DOI: 10.4067/S0716-

Morin EE, Guo L, Schwendeman A, Li XA. HDL in sepsis - risk factor and therapeutic approach. Front

Pharmacol. 2015;6:244. DOI: 10.3389/fphar.2015.00244

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign:

International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med.

;43(3):304-377. DOI: 10.1007/s00134-017-4683-6

Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science.

Intensive Care Med. 2007;33(1):13–24. DOI: 10.1007/s00134-006-0432-y

Behnes M, Brueckmann M, Liebe V, et al. Levels of oxidized low-density lipoproteins are increased in patients

with severe sepsis. J Crit Care, 2008;23(4):537–41. DOI: 10.1016/j.jcrc.2008.09.002

Capatano AL, Pirillo A, Bonacina F, Norata GD. HDL in innate and adaptive immunity. Cardiovascular

Research. 2014;103(3):372–383. DOI: 10.1093/cvr/cvu150

Norata GD, Pirillo A, Ammirati E, Catapano AL. Emerging role of high density lipoproteins as a player in the

immune system. Atherosclerosis. 2012;220(1):11–21. DOI: 10.1016/j.atherosclerosis.2011.06.045

Shor R, Wainstein J, Oz D, Boaz M, Matas Z, Fux A, Halabe A. Low HDL levels and the risk of death, sepsis

and malignancy. Clin Res Cardiol. 2008;97(4):227-33. DOI: 10.1007/s00392-007-0611-z

Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor

prognostic factor for severe sepsis. Crit Care Med, 2005;33(8):1688-1693.

DOI: 10.1097/01.ccm.0000171183.79525.6b

Rodríguez-Sanz A, Fuentes B, Martínez-Sánchez P, Prefasi D, Martínez-Martínez M, Correas E, et al. High-

Density Lipoprotein: A Novel Marker for Risk of In-Hospital Infection in Acute Ischemic Stroke Patients Cerebrovasc Dis, 2013; 35(3):291–297. DOI: 10.1159/000347077

Atogo-Asse, Vincent RP, Hughes SA, Auzinger G, Le Roux CW, Wendon J, Bernal W. High density

lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness. Liver Int.

;32(1):128-36. DOI: 10.1111/j.1478-3231.2011.02657.x

Additional Files

Published

2020-10-09

How to Cite

1.
Tejeda-Jaraba C, Echtay-Martínez A, Espinoza-Díaz C, Herrera-Castillo A, Añez R, Salazar J. Low High Density Lipoproteins in sepsis: an associated factor with worst prognosis. Ciencia e Innovación en Salud [Internet]. 2020 Oct. 9 [cited 2026 Apr. 25];. Available from: https://revistas.unisimon.edu.co/index.php/innovacionsalud/article/view/4252

Issue

Section

ORIGINALS

Most read articles by the same author(s)